Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Circulation Research
|
August 31, 2012
Acute psychological stress accelerates reverse cholesterol transport via corticosterone-dependent inhibition of intestinal cholesterol absorption
Reija Silvennoinen, Joan Carles Escola-Gil, Josep Julve, et al.
Advances in Therapy
|
November 19, 2020
Treatment Pattern and Outcomes in Newly Diagnosed Multiple Myeloma Patients Who Did Not Receive Autologous Stem Cell Transplantation: A Real-World Observational Study : Treatment pattern and outcomes in patients with multiple myeloma
Jianming He, Luke Schmerold, Rian Van Rampelbergh, et al.
Blood Advances
|
December 7, 2020
A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma
Nikhil C Munshi, Herve Avet-Loiseau, Kenneth C Anderson, et al.
Cancer Medicine
|
July 28, 2025
Real-World Treatment Patterns and Outcomes in Patients With Relapsed/Refractory Multiple Myeloma and 1-3 Prior Lines of Therapy: Optum Database
Binod Dhakal, Hermann Einsele, Jordan M Schecter, et al.
Journal of Medical Economics
|
February 17, 2026
Indirect treatment comparison of DVRd plus DR maintenance (PERSEUS study) versus DVTd or VTd with or without lenalidomide maintenance in transplant-eligible patients with previously untreated multiple myeloma
Meletios A Dimopoulos, Mario Boccadoro, Hermann Einsele, et al.
American Journal of Hematology
|
January 28, 2022
Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial
Evangelos Terpos, Meletios A Dimopoulos, Mario Boccadoro, et al.
Advances in Therapy
|
August 6, 2025
Comparative Effectiveness of Ciltacabtagene Autoleucel in CARTITUDE-4 Versus Real-World Physician's Choice of Therapy from the Flatiron Registry in Lenalidomide-Refractory Multiple Myeloma
Cyrille Touzeau, Brea Lipe, Abdullah M Khan, et al.
Immunotherapy
|
November 24, 2020
Front-line daratumumab-VTd versus standard-of-care in ASCT-eligible multiple myeloma: matching-adjusted indirect comparison
Philippe Moreau, Benjamin Hebraud, Thierry Facon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2025
Erratum: Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial
Aurore Perrot, Thierry Facon, Torben Plesner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2020
Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial
Aurore Perrot, Thierry Facon, Torben Plesner, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Circulation Research
|
August 31, 2012
Acute psychological stress accelerates reverse cholesterol transport via corticosterone-dependent inhibition of intestinal cholesterol absorption
Reija Silvennoinen, Joan Carles Escola-Gil, Josep Julve, et al.
Advances in Therapy
|
November 19, 2020
Treatment Pattern and Outcomes in Newly Diagnosed Multiple Myeloma Patients Who Did Not Receive Autologous Stem Cell Transplantation: A Real-World Observational Study : Treatment pattern and outcomes in patients with multiple myeloma
Jianming He, Luke Schmerold, Rian Van Rampelbergh, et al.
Blood Advances
|
December 7, 2020
A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma
Nikhil C Munshi, Herve Avet-Loiseau, Kenneth C Anderson, et al.
Cancer Medicine
|
July 28, 2025
Real-World Treatment Patterns and Outcomes in Patients With Relapsed/Refractory Multiple Myeloma and 1-3 Prior Lines of Therapy: Optum Database
Binod Dhakal, Hermann Einsele, Jordan M Schecter, et al.
Journal of Medical Economics
|
February 17, 2026
Indirect treatment comparison of DVRd plus DR maintenance (PERSEUS study) versus DVTd or VTd with or without lenalidomide maintenance in transplant-eligible patients with previously untreated multiple myeloma
Meletios A Dimopoulos, Mario Boccadoro, Hermann Einsele, et al.
American Journal of Hematology
|
January 28, 2022
Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial
Evangelos Terpos, Meletios A Dimopoulos, Mario Boccadoro, et al.
Advances in Therapy
|
August 6, 2025
Comparative Effectiveness of Ciltacabtagene Autoleucel in CARTITUDE-4 Versus Real-World Physician's Choice of Therapy from the Flatiron Registry in Lenalidomide-Refractory Multiple Myeloma
Cyrille Touzeau, Brea Lipe, Abdullah M Khan, et al.
Immunotherapy
|
November 24, 2020
Front-line daratumumab-VTd versus standard-of-care in ASCT-eligible multiple myeloma: matching-adjusted indirect comparison
Philippe Moreau, Benjamin Hebraud, Thierry Facon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2025
Erratum: Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial
Aurore Perrot, Thierry Facon, Torben Plesner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2020
Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial
Aurore Perrot, Thierry Facon, Torben Plesner, et al.
Page
of 7